Promoting growth in chronic inflammatory disease: Lessons from studies of the growth plate

Hormone Research

Volumn 72, Issue SUPPL. 1, 2009, Pages 42-47

  Ahmed, S F ^a   Savendahl L ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Children; Glucocorticoids; Growth; Inflammatory disease

Indexed keywords

CYTOKINE; DEXAMETHASONE; ETANERCEPT; EYE DROPS; GLUCOCORTICOID; GROWTH HORMONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; SOMATOMEDIN C; SOMATOSTATIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY;

ARTICLE; BONE DENSITY; BONE GROWTH; CHONDROGENESIS; CHRONIC INFLAMMATION; CORTICOSTEROID THERAPY; DISEASE CONTROL; DRUG MEGADOSE; GROWTH DISORDER; GROWTH PLATE; GROWTH RETARDATION; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LONG TERM CARE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIDE EFFECT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; CHILD; CHONDROGENESIS; GLUCOCORTICOIDS; GROWTH; GROWTH DISORDERS; GROWTH HORMONE; GROWTH PLATE; HUMANS; INFLAMMATION; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-1BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 73649121299     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000229763     Document Type: Article

References (28)

1. Guevara-Aguirre J, Rosenbloom AL, Vasconez O, Martinez V, Gargosky SE, Allen L, Rosenfeld RG: Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency. J Clin Endocrinol Metab 1997; 82: 629-633
2. Sims NA, Clement-Lacroix P, Da Ponte F, Bouali Y, Binart N, Moriggl R, Goffin V, Coschigano K, Gaillard-Kelly M, Kopchick J, Baron R, Kelly PA: Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. J Clin Invest 2000; 106: 1095-1103
3. Isaksson OG, Jansson JO, Gause IA: Growth hormone stimulates longitudinal bone growth directly. Science 1982; 216: 1237-1239
4. Isgaard J, Moller C, Isaksson OG, Nilsson A, Mathews LS, Norstedt G: Regulation of insulin-like growth factor messenger ribonucleic acid in rat growth plate by growth hormone. Endocrinology 1988; 122: 1515-1520
5. Schlechter NL, Russell SM, Spencer EM, Nicoll CS: Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin. Proc Natl Acad Sci USA 1986; 83: 7932-7934
6. Silvestrini G, Ballanti P, Patacchioli FR, Mocetti P, Di Grezia R, Wedard BM, Angelucci L, Bonucci E: Evaluation of apoptosis and the glucocorticoid receptor in the cartilage growth plate and metaphyseal bone cells of rats after high-dose treatment with corticosterone. Bone 2000; 26: 33-42
7. Chrysis D, Ritzen EM, Sävendahl L: Growth retardation induced by dexamethasone is associated with increased apoptosis of the growth plate chondrocytes. J Endocrinol 2003; 176: 331-337
8. Kugelberg M, Shafiei K, Ohlsson C, Sävendahl L, Zetterström C: Glucocorticoid eye drops inhibit growth in the newborn rabbit. Acta Paediatr 2005; 94: 1096-1101
9. Kugelberg M, Shafiei K, Ohlsson C, Zetterström C, Sävendahl L: Reduced bone mineral density and radial bone growth in young rabbits treated with dexamethasone eye drops. Horm Res 2005; 63: 165-170
10. Baron J, Huang Z, Oerter KE, Bacher JD, Cutler GB Jr: Dexamethasone acts locally to inhibit longitudinal bone growth in rabbits. Am J Physiol 1992; 263: 489-492
11. Mushtaq T, Seawright E, Farquharson C, Ahmed SF: Glucocorticoid effects on chondrogenesis, differentiation and apoptosis on the ATDC5 chondrocyte cell line. J Endocrinol 2002; 175: 705-713
12. Mushtaq T, Bijman P, Ahmed SF, Farquharson C: Insulin like growth factor-I augments chondrocyte hypertrophy and reverses glucocorticoid mediated growth retardation in fetal mice metatarsal cultures. Endocrinology 2004; 145: 2478-2486
13. Chrysis D, Zaman F, Chagin AS, Takigawa M, Sävendahl L: Dexamethasone induces apoptosis in proliferative chondrocytes through activation of caspases and suppression of the Akt-(PI3K) signaling pathway. Endocrinology 2005; 146: 1391-1397
14. MacRae VE, Mushtaq T, Ahmed SF, Farquharson C: IGF-I signaling in bone growth: inhibitory actions of dexamethasone and IL-1beta. Growth Horm IGF Res 2007; 17: 435-439
15. Owen HC, Miner JN, Ahmed SF, Farquharson C: The growth plate sparing effects of the selective glucocorticoid receptor modulator, AL-438. Mol Cell Endocrinol 2007; 264: 164-170
16. Barbosa APF, Silva JDP, Fonseca EC, Lopez PM, Fernandes MBC, Balduino A, Duarte MEL: Response of the growth plate of uremic rats to human growth hormone and corticosteroids. Braz J Med Biol Res 2007; 40: 1101-1109
17. Joronen K, Ala-aho R, Majuri ML, Alenius H, Kähäri VM, Vuorio E: Adenovirus mediated intra-articular expression of collagenase-3 (MMP-13) induces inflammatory arthritis in mice. Ann Rheum Dis 2004; 63: 656-664
18. de Hooge AS, van de Loo FA, Bennink MB, Arntz OJ, Fiselier TJ, Franssen MJ, Joosten LA, Van Lent PL, Richards CD, van den Berg WB: Growth plate damage, a feature of juvenile idiopathic arthritis, can be induced by adenoviral gene transfer of oncostatin M: a comparative study in gene-deficient mice. Arthritis Rheum 2003; 48: 1750-1761
19. MacRae VE, Wong SC, Smith W, Gracie A, McInnes I, Galea P, Gardner-Medwin J, Farquharson C, Ahmed SF: Cytokine profiling and in-vitro studies of metatarsal growth using biological fluids from children with juvenile idiopathic arthritis. Clin Endocrinol (Oxford) 2007; 67: 442-448
20. Wong SC, MacRae VE, Smith W, Gracie A, McInnes I, Galea P, Gardner-Medwin J, Ahmed SF: Inflammatory cytokines in juvenile idiopathic arthritis: effects on physical growth and the insulin-like-growth factor axis. Growth Horm IGF Res 2008; 18: 369-378
21. Martensson K, Chrysis D, Sävendahl L: Interleukin-1 beta and TNF-alpha act in synergy to inhibit longitudinal growth in fetal rat metatarsal bones. J Bone Miner Res 2004; 19: 1805-1812
22. MacRae VE, Farquharson C, Ahmed SF: The restricted potential for recovery of growth plate chondrogenesis and longitudinal bone growth following exposure to pro-inflammatory cytokines. J Endocrinol 2006; 189: 319-328
23. Söder O, Madsen K: Stimulation of chondrocyte DNA synthesis by interleukin-1. Br J Rheumatol 1988; 27: 21-26
24. Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, Leeb B, Breedveld FC, Macfarlane JD, Bijl H, Woody JN: Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 1994; 344: 1105-1110
25. Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Whitmore J, Finck BK: Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med 2000; 342: 763-769
26. Schmeling H, Seliger E, Horneff G: Growth reconstitution in juvenile idiopathic arthritis treated with etanercept. Clin Exp Rheumatol 2003; 21: 779-784
27. Tynjala P, Lahdenne P, Vahasalo P, Kautiainen H, Honkanen V: Impact of anti-TNF treatment on growth in severe juvenile idiopathic arthritis. Ann Rheum Dis 2006; 65: 1044-1049
28. Fernandéz P, Hansen JB, Andersson U, Sävendahl S, Hagelberg S: Etanercept treatment improves longitudinal growth in prepubertal children with juvenile idiopathic arthritis. J Rheumatol 2007; 34: 2481-2485